Additionally, hyperglycemia, a key clinical manifestation of diabetes, also produces ROS via NADPH oxidase activation by glycation end products [40], while blocking of ROS formation is known to prevent hyperglycemic damage [41]. Here, FMO5 is linked to diabetes mellitus.